冠脉功能检查指导非阻塞性冠脉心绞痛治疗:ILIAS ANOCA试验
ILIAS ANOCA试验在153例非阻塞性冠脉心绞痛患者中比较常规冠脉功能检查(CFT)联合疾病特异性治疗与标准治疗。
要点
- 常规CFT在初次冠脉造影时可行安全,血管运动障碍检出率达78%。
- CFT结果指导的疾病特异性治疗显著改善6个月生活质量。
- 6个月随访无主要不良心脏事件发生。
核心结论
- 常规CFT联合疾病特异性治疗可显著改善ANOCA患者疾病相关生活质量。
研究设计与样本
- 随机对照试验,255例知情同意,153例无阻塞性CAD患者1:1随机至标准治疗组(n=76)或干预组(n=77)。
主要发现
- 120例(78%)检出血管运动障碍。
- 所有CFT操作成功且无不良事件,6个月随访无主要不良心脏事件。
关键数值与推荐
- CFT在初次ICA时进行,干预组公开CFT结果并给予定制药物治疗方案。
- 主要结局为6个月SAQSS组内变化均值差异。
临床怎么用
- 对ANOCA患者可在初次造影时行CFT以早期全面诊断,并依据结果启动疾病特异性治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Invasive coronary function testing (CFT) identifies coronary vasomotor disorders in up to 90% of patients with angina with non-obstructive coronary arteries (ANOCA). The ILIAS ANOCA trial hypothesized that routine ad hoc CFT would be feasible, safe, and effective in providing an early, comprehensive diagnosis. Additionally, it was anticipated that combining CFT with a disease-specific treatment protocol would significantly improve quality of life in ANOCA patients compared with standard care. METHODS: After excluding patients with obstructive coronary artery disease (CAD) during clinically indicated invasive coronary angiography (ICA), eligible patients underwent CFT and were randomized to either the standard care group, where CFT results remained blinded, or the intervention group, where CFT results were disclosed along with a tailored medical therapy protocol. The primary outcome was the mean difference in the within-subject change in Seattle Angina Questionnaire summary score (SAQSS) between groups from baseline to a follow-up of 6 months. The trial is registered with the International Clinical Trials Registry Platform (NL-OMON20739). RESULTS: A total of 255 patients consented, of whom 153 patients (60%) without CAD underwent CFT and were randomized 1:1 to the standard care (n = 76) or intervention group (n = 77). All CFT procedures were successful without adverse events. A vasomotor disorder was identified in 120 patients (78%). At 6-month follow-up, the SAQSS improved significantly in the intervention group compared with the control group, with an intervention effect of 9.4 units (95% confidence interval 3.9-14.9, P = .001). There were no major adverse cardiac events at the 6-month follow-up. CONCLUSIONS: Routine CFT during the initial ICA was feasible, safe, and had high diagnostic yield. Implementing a pragmatic CFT protocol combined with a disease-specific treatment protocol significantly improved disease-related quality of life in patients with ANOCA compared with standard care.
引用
- Boerhout CKM, Namba HF, Liu T, et al. Coronary function testing vs angiography alone to guide treatment of angina with non-obstructive coronary arteries: the ILIAS ANOCA trial. Eur Heart J. 2025. PMID: 40796241. doi:10.1093/eurheartj/ehaf580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。